Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision (v3.6.0) was added, including the recruitment status note 'No longer looking for participants', indicating the study is not enrolling. The older revision identifier (v3.5.5) was removed from the history.SummaryDifference0.6%

- Check19 days agoChange DetectedA new revision entry v3.5.5 was added to the study history and the v3.5.4 entry was removed, updating the record’s version history.SummaryDifference0.1%

- Check41 days agoChange DetectedA new 'Revision: v3.5.4' entry was added to the record history, replacing the previous version tag. This update reflects a minor change to the page's versioning metadata rather than substantive content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s displayed application/release revision updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the study record itself.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check98 days agoChange DetectedThe history log now shows an addition of Revision v3.5.0 and a deletion of Revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.